Trial NCT00089414

View at ClinicalTrials.gov 
Org. Study IDs: 040221
Secondary IDs: 04-M-0221

Last trial update was posted on 2017-08-25

MeSH Interventions

Drospirenone Drospirenone and ethinyl estradiol combination Estradiol Ethinyl Estradiol Progesterone

MeSH Conditions

Depression Premenstrual Dysphoric Disorder Premenstrual Syndrome

Other Conditions

PMDD PMS

Stopping Reasons

Informed by manufacturer that CDB-2914 crosses blood-brain barrier invalidating Arm #3 of protocol.

Limitations And Caveats

Protocol terminated after receiving information from manufacturer (Pharma) that CDB-2914 crosses the blood-brain barrier, invalidating Arm #3 due to potential CNS effect of the compound on behavior.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID